We are experiencing some temporary issues. The market data on this page is currently delayed. Please bear with us as we address this and restore your personalized lists.
S&P Futures
5,178.75 +11.25 (+0.22%) Dow Futures
38,308.00 +70.00 (+0.18%) Nasdaq Futures
18,224.50 +45.25 (+0.25%) Russell 2000 Futures
2,030.00 +10.20 (+0.50%) Crude Oil
85.43 -0.23 (-0.27%) Gold
2,370.90 -3.20 (-0.13%)
Baxter International Inc. (BAX)
After hours:
Chart Events
Performance Outlook
| Previous Close | 42.12 |
| Open | 41.74 |
| Bid | 40.04 x 900 |
| Ask | 41.16 x 900 |
| Day's Range | 40.21 - 41.90 |
| 52 Week Range | 31.01 - 50.21 |
| Volume | |
| Avg. Volume | 3,628,548 |
| Market Cap | 20.542B |
| Beta (5Y Monthly) | 0.63 |
| PE Ratio (TTM) | N/A |
| EPS (TTM) | -0.15 |
| Earnings Date | May 02, 2024 |
| Forward Dividend & Yield | 1.16 (2.88%) |
| Ex-Dividend Date | Feb 29, 2024 |
| 1y Target Est | 45.00 |
Fair Value
Subscribe to Yahoo Finance Plus to view Fair Value for BAX
Related Research
- Baxter International Inc.Morningstar | A Weekly Summary of Stock Ideas and Developments in the Companies We CoverIn this edition, obesity drug's effect on dialysis may be muted; looking at the upcoming commercial real estate cycle; and taking the US economic pulse; and Amcor PLC, Sinopharm Group, and Hennes & Mauritz.RatingFair ValueEconomic Moat17 days agoMorningstar
ZacksBaxter's (BAX) New Injectables Aid Its Pharmaceutical Portfolio
Baxter (BAX) unveils its five injectable products, which strengthen its emphasis on unique products and expand the pharmaceutical portfolio of the business in important therapeutic areas.
ZacksComfort Systems USA and Boeing have been highlighted as Zacks Bull and Bear of the Day
Comfort Systems USA and Boeing are part of the Zacks Bull and Bear of the Day article.
Zacks3 Medical Device Stocks With Solid Dividend Yield: CAH & Others
Here we discuss three medical device stocks, Cardinal Health (CAH), Baxter International (BAX) and Fresenius Medical Care (FMS), with a solid five-year dividend growth history.
Business WireBaxter Expands Pharmaceuticals Portfolio with New Injectable Products in the U.S.
DEERFIELD, Ill., April 11, 2024--Baxter International Inc. (NYSE:BAX), a global leader in injectables, anesthesia and drug compounding, announced the continued expansion of its Pharmaceuticals portfolio with five injectable product launches in the U.S.
- Business Wire
Baxter to Host First-Quarter 2024 Financial Results Conference Call for Investors
DEERFIELD, Ill., April 10, 2024--Baxter International Inc. (NYSE:BAX), a global medtech leader, will host a conference call to discuss its first-quarter 2024 financial results on Thursday, May 2, 2024 at 7:30 a.m. Central Time. To participate in this conference call please follow this link https://registrations.events/direct/Q4I215737 to pre-register for the call and receive the call information.
ZacksReasons to Hold Baxter International (BAX) in Your Portfolio
Baxter International's (BAX) robust growth across all geographies, along with transformational initiatives, raises optimism.
GuruFocus.comBaxter Is Deeply Undervalued
The company is undergoing a transformation to a focused health care player
Simply Wall St.Shareholders in Baxter International (NYSE:BAX) are in the red if they invested three years ago
For many investors, the main point of stock picking is to generate higher returns than the overall market. But if you...
- Zacks
Baxter's (BAX) Latest FDA Approval to Boost Infusion Therapy
Baxter's (BAX) Novum IQ Infusion Platform is likely to help enhance patient safety and efficiency for clinicians following the FDA's clearance.
Business WireBaxter Announces U.S. FDA Clearance of Novum IQ Large Volume Infusion Pump and Dose IQ Safety Software, Advancing Connected and Intelligent Infusion Therapy
DEERFIELD, Ill., April 01, 2024--Baxter International Inc. (NYSE:BAX), an innovative leader in infusion therapies and technologies, today announced U.S. Food and Drug Administration (FDA) 510(k) clearance of its Novum IQ large volume infusion pump (LVP) with Dose IQ Safety Software. Adding LVP modality to the Novum IQ Infusion Platform – which includes Baxter’s syringe infusion pump (SYR) with Dose IQ Safety Software, powered by the IQ Enterprise Connectivity Suite – enables clinicians to utiliz
Morningstar Rating
Rating
Fair Value
Economic Moat
People Also Watch
| Symbol | Last Price | Change | % Change |
|---|---|---|---|
| BDX Becton, Dickinson and Company | |||
| EW Edwards Lifesciences Corporation | |||
| CAH Cardinal Health, Inc. | |||
| BSX Boston Scientific Corporation | |||
| SYK Stryker Corporation |
Similar to BAX
| Symbol | Last Price | Change | % Change |
|---|---|---|---|
| BDX Becton, Dickinson and Company | |||
| TFX Teleflex Incorporated | |||
| HOLX Hologic, Inc. | |||
| BLCO Bausch + Lomb Corporation | |||
| ALC Alcon Inc. |
Analyst Price Targets (12)
Upgrades & Downgrades
| Maintains | Citigroup: Neutral to Neutral | 4/3/2024 | |
| Maintains | B of A Securities: Neutral to Neutral | 3/5/2024 | |
| Maintains | Barclays: Overweight to Overweight | 2/12/2024 | |
| Maintains | JP Morgan: Neutral to Neutral | 2/9/2024 | |
| Maintains | Morgan Stanley: Equal-Weight to Equal-Weight | 12/4/2023 | |
| Maintains | JP Morgan: Neutral to Neutral | 10/31/2023 |
Company Profile
One Baxter Parkway
Deerfield, IL 60015
United States
224 948 2000
https://www.baxter.com
Sector(s): Healthcare
Industry: Medical Instruments & Supplies
Full Time Employees: 60,000
Baxter International Inc., through its subsidiaries, develops and provides a portfolio of healthcare products worldwide. The company operates through four segments: Medical Products and Therapies, Healthcare Systems and Technologies, Pharmaceuticals, and Kidney Care. The company offers sterile intravenous (IV) solutions; infusion systems and devices; parenteral nutrition therapies; generic injectable pharmaceuticals; surgical hemostat and sealant products, advanced surgical equipment; smart bed systems; patient monitoring and diagnostic technologies; and respiratory health devices, as well as advanced equipment for the surgical space, including surgical video technologies, precision positioning devices, and other accessories. It also provides administrative sets; adhesion prevention products; inhaled anesthesia; drug compounding; chronic and acute dialysis therapies and services, including peritoneal dialysis (PD), hemodialysis (HD), continuous renal replacement therapies (CRRT), and other organ support therapies. The company's products are used in hospitals, kidney dialysis centers, nursing homes, rehabilitation centers, ambulatory surgery centers, doctors' offices, and patients at home under physician supervision. The company sells its products through direct sales force, as well as through independent distributors, drug wholesalers, and specialty pharmacy or other alternate site providers in approximately 100 countries. It has an agreement with Celerity Pharmaceutical, LLC to develop acute care generic injectable premix and oncolytic products; and a collaborative research agreement with Miromatrix Medical Inc. aiming to advance care for patients with acute liver failure. Baxter International Inc. was incorporated in 1931 and is headquartered in Deerfield, Illinois.
